Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC2A1 | P11166 | 8/20 | 0.37 |
| ▸ | KCNH2 | Q12809 | 2/20 | 0.36 |
| ▸ | MTNR1A | P48039 | 1/20 | 0.35 |
| ▸ | MTNR1B | P49286 | 1/20 | 0.35 |
| ▸ | LMNA | P02545 | 1/20 | 0.34 |
| ▸ | POLB | P06746 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5444230 | 1.00 | SLC2A1 (0.37) | SLC2A1KCNH2MTNR1AMTNR1BLMNA | |
| SCHEMBL5317252 | 0.91 | MTNR1A (0.36) | SLC2A1KCNH2MTNR1AMTNR1B | |
| SCHEMBL5317247 | 0.91 | MTNR1A (0.36) | SLC2A1KCNH2MTNR1AMTNR1B | |
| SCHEMBL3780351 | 0.88 | KCNH2 (0.48) | SLC2A1KCNH2MTNR1AMTNR1B | |
| SCHEMBL3780360 | 0.88 | KCNH2 (0.48) | SLC2A1KCNH2MTNR1AMTNR1B | |
| SCHEMBL3697142 | 0.81 | SLC2A1 (0.47) | SLC2A1KCNH2 | |
| SCHEMBL3697147 | 0.81 | SLC2A1 (0.47) | SLC2A1KCNH2 | |
| SCHEMBL5264168 | 0.79 | MTNR1B (0.41) | SLC2A1KCNH2MTNR1AMTNR1B | |
| SCHEMBL5426776 | 0.79 | KMT2A (0.44) | SLC2A1MTNR1AMTNR1B | |
| SCHEMBL3688107 | 0.78 | KCNH2 (0.47) | SLC2A1KCNH2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20070244103-A1 | Novel Compounds Having an Anti-Bacterial Activity | MORPHOCHEM AKTIENGESELLSCHAFT FUR KOMBINATORISCHE CHEMIE (DE) | 2007-10-18 | — | — | US | disclosed |
| US-20070244103-A1 | Novel Compounds Having an Anti-Bacterial Activity | MORPHOCHEM AKTIENGESELLSCHAFT FUR KOMBINATORISCHE CHEMIE (DE) | 2007-10-18 | — | — | US | disclosed |
| US-20070244103-A1 | Novel Compounds Having an Anti-Bacterial Activity | MORPHOCHEM AKTIENGESELLSCHAFT FUR KOMBINATORISCHE CHEMIE (DE) | 2007-10-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070244103-A1 | Novel Compounds Having an Anti-Bacterial Activity | TOP1, TOP2A, TOP2B | SLC2A1 4714/4885KCNH2 3363/4885MTNR1A 4243/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.